IBEX Technologies Inc (IBT) - Financial Analysis Review

Summary

IBEX Technologies Inc (IBEX) is a biopharmaceutical company that markets recombinant high-purity proprietary enzymes from flavobacterium heparinum. The companys enzymes include heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. IBEX assays allow for the study of both the synthesis and degradation of connective tissue components and are powerful tools. It offers cartilage degradation assays, such as C2C and C1-2C; and collagen synthesis assays including, CPII and CS-846. The company also offers contract manufacturing programs and produces a series of arthritis assays which are used by pharmaceutical companies for research purposes.

GlobalData's IBEX Technologies Inc (IBT) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

IBEX Technologies Inc Key Recent Developments:

Nov 04,2016: IBEX Reports Results for The Year Ended July 31, 2016
Jun 21,2016: IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2016
Mar 17,2016: IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2016
Dec 17,2015: IBEX Reports First Quarter Fiscal 2016 Results
Nov 05,2015: IBEX Reports Results for the Year Ended July 31, 2015


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.